Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Dose Increments in Resistant PCOS
NCT06403488Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in polycystic ovary syndrome (PCOS), sponsored by Beni Suef University. Started Oct 2023; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06403488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06403488.